Pharmaceutical Investing Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Pharmaceutical Investing Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Pharmaceutical Investing Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
Pharmaceutical Investing Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
Pharmaceutical Investing Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm
Homerun Resources Inc. Receives Conditional Approval from the TSXV for $6 Million Financing with Institutional Investor
Silver Dollar Samples Up to 2,753 g/t AgEq in Underground Sampling Campaign at its La Joya Silver Project
